PA8 Stock Overview
Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and intensive care medicine services worldwide.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Paion AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.36 |
52 Week High | €8.96 |
52 Week Low | €0.22 |
Beta | 1.68 |
1 Month Change | 0% |
3 Month Change | 4.35% |
1 Year Change | -94.90% |
3 Year Change | -98.54% |
5 Year Change | -98.41% |
Change since IPO | -99.60% |
Recent News & Updates
Recent updates
Here's Why We're Not At All Concerned With Paion's (ETR:PA8) Cash Burn Situation
Nov 17Results: Paion AG Beat Earnings Expectations And Analysts Now Have New Forecasts
Apr 03Paion AG's (ETR:PA8) Stock Has Fared Decently: Is the Market Following Strong Financials?
Feb 09Did You Miss Paion's (ETR:PA8) 28% Share Price Gain?
Dec 15Shareholder Returns
PA8 | DE Biotechs | DE Market | |
---|---|---|---|
7D | 0% | 2.2% | -1.3% |
1Y | -94.9% | 38.4% | 4.2% |
Rendite im Vergleich zur Industrie: PA8 unter dem Niveau der Branche German Biotechs , die im vergangenen Jahr eine Rendite von -23.4% erzielte.
Rendite vs. Markt: PA8 hinter dem Markt German zurück, der im vergangenen Jahr eine Rendite von 4.7 erzielte.
Price Volatility
PA8 volatility | |
---|---|
PA8 Average Weekly Movement | n/a |
Biotechs Industry Average Movement | 5.4% |
Market Average Movement | 4.7% |
10% most volatile stocks in DE Market | 9.8% |
10% least volatile stocks in DE Market | 2.4% |
Stabiler Aktienkurs: PA8Der Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.
Volatilität im Zeitverlauf: Unzureichende Daten, um die Volatilitätsveränderung von PA8 im vergangenen Jahr zu bestimmen.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | 64 | Tilmann Bur | https://www.paion.com |
Paion AG Fundamentals Summary
PA8 fundamental statistics | |
---|---|
Market cap | €2.57m |
Earnings (TTM) | -€19.86m |
Revenue (TTM) | €14.81m |
0.2x
P/S Ratio-0.1x
P/E RatioIs PA8 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PA8 income statement (TTM) | |
---|---|
Revenue | €14.81m |
Cost of Revenue | €6.35m |
Gross Profit | €8.46m |
Other Expenses | €28.32m |
Earnings | -€19.86m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -2.78 |
Gross Margin | 57.15% |
Net Profit Margin | -134.12% |
Debt/Equity Ratio | -675.5% |
How did PA8 perform over the long term?
See historical performance and comparison